Jacques Dumas, Chief Scientific Officer at TETRAPHASE PHARMACEUTICALS INC (TTPH), sold 8,750 shares at $6.22 ($54K) on 2018-01-30, disclosed to the SEC on 2018-01-31.
Open-market sale of $54k TTPH by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TTPH | SELL | 2017-11-02 | $106K | — | Filing → |
| TTPH | SELL | 2017-08-24 | $105K | — | Filing → |
| TTPH | SELL | 2017-08-21 | $42K | — | Filing → |